Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin CSF Levels in Healthy Adults
NCT05866367Phase 1Terminated
- Sponsor
- HealthPartners Institute
- Start
- Aug 2023
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of human insulin in Mild Cognitive Impairment (MCI), Dementia and Alzheimer's disease (AD) (2 arms), sponsored by HealthPartners Institute. Primary endpoints: Insulin Concentration Over Time - Cerebrospinal Fluid, Cmax of Insulin Concentration - Cerebrospinal Fluid and 2 more. Started Aug 2023; status: terminated.
02
Drugs
human insulin
03
Conditions
Mild Cognitive Impairment (MCI)DementiaAlzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05866367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866367.